Form 8-K - Current report:
SEC Accession No. 0001104659-24-108914
Filing Date
2024-10-16
Accepted
2024-10-16 06:30:13
Documents
14
Period of Report
2024-10-16
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425466d1_8k.htm   iXBRL 8-K 26901
  Complete submission text file 0001104659-24-108914.txt   238609

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20241016.xsd EX-101.SCH 3254
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20241016_def.xml EX-101.DEF 26569
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20241016_lab.xml EX-101.LAB 36011
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20241016_pre.xml EX-101.PRE 25184
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2425466d1_8k_htm.xml XML 4302
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 241373251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)